Q4: 2026-02-12 Earnings Summary
EPS of $0.56 beats by $0.01
| Revenue of $760.60M (1.89% Y/Y) beats by $12.44M
Avient Corporation (AVNT) Q4 2025 Earnings Call February 12, 2026 8:00 AM EST
Company Participants
Giuseppe Di Salvo – VP of Investor Relations & Treasurer
Ashish Khandpur – President, CEO & Chairman of the Board
Jamie Beggs – Senior VP & CFO
Conference Call Participants
Michael Sison – Wells Fargo Securities, LLC, Research Division
Daniel Rizzo – Jefferies LLC, Research Division
Frank Mitsch – Fermium Research, LLC
Kristen Owen – Oppenheimer & Co. Inc., Research Division
Michael Harrison – Seaport Research Partners
Emily Fusco – Deutsche Bank AG, Research Division
Ghansham Panjabi – Robert W. Baird & Co. Incorporated, Research Division
Turner Hinrichs – Morgan Stanley, Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Avient Corporation’s webcast to discuss the company’s fourth quarter and full year 2025 results. My name is Michelle, and I’ll be your operator for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the call over to Joe Di Salvo, Vice President, Treasurer, Investor Relations. Please proceed.
Giuseppe Di Salvo
VP of Investor Relations & Treasurer
Thank you, and good morning, everyone, to joining us on the call today. Before we begin, we’d like to remind you that statements made during this webcast may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements will give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectation and involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
We encourage you to review our most recent reports, including our 10-K or any applicable amendments for a complete discussion of these factors and other risks
